title: HPV and oral lesions: preventive possibilities, vaccines and early diagnosis of malignant lesions.
abstract: The importance of HPV in world healthy is high, in fact high-risk HPV types contribute significantly to viral associated neoplasms. In this article we will analyze vary expression of HPV in oral cavity both benign and malignant, their prevalence and the importance in early diagnosis and prevention. The classical oral lesions associated with human papillomavirus are squamous cell papilloma, condyloma acuminatum, verruca vulgaris and focal epithelial hyperplasia. Overall, HPV types 2, 4, 6, 11, 13 and 32 have been associated with benign oral lesions while HPV types 16 and 18 have been associated with malignant lesions, especially in cancers of the tonsils and elsewhere in the oropharynx. Transmission of the virus can occur with direct contact, genital contact, anal and oral sex; latest studies suggest a salivary transmission and from mother to child during delivery. The number of lifetime sexual partners is an important risk factor for the development of HPV-positive head-neck cancer. Oral/oropharyngeal cancer etiologically associated with HPV having an increased survival and a better prognostic (85%-90% to five years). There is no cure for the virus. There are two commercially available prophylactic vaccines against HPV today: the bivalent (16 and 18) Cervarix® and the tetravalent (6, 11, 16 and 18) Gardasil® and new vaccine Gardasil 9 (6, 11, 16, 18, 31, 33, 45, 52, 58) was approved in the United States. To be effective, such vaccination should start before "sexual puberty". The vaccine could be an important preventive strategy, in fact the scientific community is in agreement on hypothesis that blocking the contagion it may also limit the distance complications as the oropharyngeal cancer.
authors.affiliation: Graduate School in Materials for Health, Environment and Energy, University of Rome "Tor Vergata", Rome, Italy.
authors.forename: D
authors.initials: D
authors.lastname: Testi
authors.affiliation: Medical Director of the Health Professions, Ministry of Health, Rome, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Nardone
authors.affiliation: Graduate School in Materials for Health, Environment and Energy, University of Rome "Tor Vergata", Rome, Italy.
authors.forename: P
authors.initials: P
authors.lastname: Melone
authors.affiliation: Department of Clinical Sciences and Translational Medicine, University of Rome "Tor Vergata", Rome, Italy.
authors.forename: P
authors.initials: P
authors.lastname: Cardelli
authors.affiliation: Department of Clinical Sciences and Translational Medicine, University of Rome "Tor Vergata", Rome, Italy.
authors.forename: L
authors.initials: L
authors.lastname: Ottria
authors.affiliation: Department of Clinical Sciences and Translational Medicine, University of Rome "Tor Vergata", Rome, Italy.
authors.forename: C
authors.initials: C
authors.lastname: Arcuri
keywords: HPV; cancer; oral lesions; papilloma virus; vaccines